Researchers Present Ozempic Alternatives—Without Sickening GI Side Effects
These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...
Daily16h
Phase 2b QUALITY Trial: Enobosarm Significantly Reduces Lean Mass Loss in Patients on Semaglutide
Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...
Winthroptranscript.com22h
GLP-1 Weight-loss Drugs Should be made Affordable for all Americans
The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...
Hosted on MSN2h
Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & More
Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...
Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca
Market focus will remain on earnings from major tech companies, in the wake of the sell-off in artificial ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Packers News23h
Matt LaFleur's mismanagement leads to his first loss against Bears as Packers head coach
GREEN BAY – Matt LaFleur’s first mistake came before the Chicago Bears even started ... If there was any consolation Sunday, it’s that the Packers loss didn’t influence their playoff seeding. Can you ...